Total results with these characteristics: 229
- Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico
This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine …
Author: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R
- The Cost-Effectiveness of Rotavirus Vaccination in Armenia
This article, published in Vaccine, evaluates the cost-effectiveness of introducing infant rotavirus vaccination in Armenia in 2012 using Rotarix(R)® using a multiple birth cohort model. The model considered the cost and health implications of …
Author: Jit M, Yuzbashyan R, Sahakyan G, Avagyan T, Mosina L
- Costs of Community-Acquired Pediatric Rotavirus Gastroenteritis in 7 European Countries: The REVEAL Study
Investigators found that rotavirus gastroenteritis incurs considerable use of health care resources and results in substantial costs for families of patients and employers. Routine rotavirus vaccination could significantly reduce the related …
Author: Giaquinto C, Van Damme P, Huet F, Gothefors L, Van der Wielen M
This website provides comprehensive resources on diarrheal disease treatment interventions, including low-osmolarity oral rehydration solution, zinc treatment, and rotavirus vaccines. Traditional interventions such as improved sanitation and …
- The Development of Live, Attenuated Rotavirus Vaccines: A Manufacturer's Resource Guide
This guide is a compilation of publicly available information about the manufacturing process of rotavirus vaccines, and aims to provide a resource for manufacturers interested in developing and registering an attenuated, oral rotavirus vaccine. …
Author: PATH, GAVI Alliance
- Diarrheal Disease: Solutions to Defeat a Global Killer
Diarrheal Disease: Solutions to Defeat a Global Killer presents scientific evidence to support strategies to scale up use of interventions, including safe water, improved sanitation and hygiene, breastfeeding and optimal complementary feeding, …
- Diarrhoea: Why Children Are Still Dying and What Can Be Done
This joint report from the World Health Organization and the United Nations Children's Fund (UNICEF) focuses attention on the prevention and management of diarrheal diseases. It examines the latest available information on the burden of childhood …
Author: World Health Organization, United Nations Children's Fund
- Direct and Indirect Effects of Rotavirus Vaccination Upon Childhood Hospitalizations in 3 US Counties, 2006–2009
This article, published in Clinical Infectious Diseases, is about an active, population-based surveillance for rotavirus gastroenteritis hospitalizations in three United States counties to assess the impact of rotavirus vaccines. The study …
Author: Payne DC, Staat MA, Edwards KM, et al.
- Diseases and the Vaccines That Prevent Them
This series of fact sheets describes symptoms of infection as well as the benefits and risk of vaccination for 14 diseases, including hepatitis B, Haemophilus influenzae type b, influenza, pneumococcal disease, polio, and rotavirus. There …
Author: US Centers for Disease Control and Prevention
- Distribution of Rotavirus Genotypes in Europe, 2004-2005: The REVEAL Study
Rotavirus genotypes were identified in several European countries using ELISA tests, and investigators determined that G1–G4 and G9 genotypes were responsible for the majority of cases. Citing these results, the authors suggest that rotavirus …
Author: Van Damme P, Giaquinto C, Maxwell M, Todd P, Van der Wielen M
- Distributional Impact of Rotavirus Vaccination in 25 GAVI Countries: Estimating Disparities in Benefits and Cost-Effectiveness
This article, published in Vaccine, reports on an analysis that combines the results of a country-level model of rotavirus vaccination published elsewhere with data from Demographic and Health Surveys on within-country patterns of vaccine coverage …
Author: Rheingans R, Atherly D, Anderson J
- A Dose-Escalation Safety and Immunogenicity Study of Live Attenuated Oral Rotavirus Vaccine 116E in Infants: A Randomized, Double-Blind, Placebo-Controlled Trial
This study, published in the Journal of Infectious Diseases, tested the neonatal rotavirus candidate vaccine 116E in a double-blind, placebo-controlled dose-escalation trial in India. Two doses of the Vero cell-adapted vaccine were evaluated in …
Author: Bhandari N, Sharma P, Taneja S, et al.
- Duration of Protection of Pentavalent Rotavirus Vaccination in Nicaragua
This article, published in Pediatrics, summarizes a case-control study conducted at four hospitals in Nicaragua to evaluate the duration of protection after rotavirus vaccination among eligible infants. The pentavalent rotavirus vaccine …
Author: Patel M, Pedreira C, De Oliveira LH, et al.
- Economic Costs of Rotavirus Gastroenteritis and Cost-Effectiveness of Vaccination in Developing Countries
This article, published in The Journal of Infectious Diseases, evaluated the economic burden of rotavirus and the cost-effectiveness of vaccination from the health care perspective. The authors found that rotavirus vaccination would annually prevent …
Author: Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD
- Economic Evaluations of Rotavirus Immunization for Developing Countries: A Review of the Literature
This article, published in Expert Review of Vaccines, analyzes the cost-effectiveness of universal rotavirus immunization in developing countries. The authors identified and evaluated 15 cost-effectiveness studies conducted in the developing world. …
Author: Tu HA, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ
- Economic Impact of a Rotavirus Vaccination Program in Mexico
This article, published in the Pan American Journal of Public Health, examines a national rotavirus vaccination program in Mexico and evaluates its costs and benefits. The article concludes that the program would be highly cost-effective and …
Author: Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y
- Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants
This article, published in The New England Journal of Medicine, discusses a study on the efficacy of rotavirus vaccine in Africa. Results showed 30.2 percent efficacy against all-cause severe gastroenteritis. The study concluded that rotavirus …
Author: Madhi SA, Cunliffe NA, Steele D, et al.
- Effect of Rotavirus Vaccination on Death From Childhood Diarrhea in Mexico
This article, published in The New England Journal of Medicine, discusses a study on the effectiveness of rotavirus vaccine in Mexico. The study examined the impact of vaccination on diarrheal deaths in Mexican children between 2008 and 2009 …
Author: Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al.
- Effect of Rotavirus Vaccine on Diarrhea Mortality in Different Socioeconomic Regions of Mexico
This article, published in Pediatrics, concludes that after the 2007 introduction of rotavirus vaccine in Mexico, marked and sustained declines in diarrhea deaths were seen among children in all regions of the country, including in the least …
Author: Gastañaduy PA, Sánchez-Uribe E, Esparza-Aguilar M, et al.
- Effectiveness of Monovalent Rotavirus Vaccine in Bolivia: Case-Control Study
This article, published in BMJ, reports on a study that evaluated the effectiveness of two doses of a monovalent rotavirus vaccine against hospital admission for rotavirus at six hospitals in Bolivia, between March 2010 and June 2011. Results show …
Author: Patel MM, Patzi M, Pastor D, et al.
- Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children <5 Years of Age, 2009–2011
This article, published in Clinical Infectious Diseases, summarizes a study that assessed vaccine effectiveness of RotaTeq (RV5; 3 doses) and Rotarix (RV1; 2 doses) at reducing rotavirus acute gastroenteritis inpatient and emergency department (ED) …
Author: Payne DC, Boom JA, Staat MA, et al.
- Efficacy of a Monovalent Human-Bovine (116E) Rotavirus Vaccine in Indian Infants: A Randomised, Double-Blind, Placebo-Controlled Trial
This article, published in The Lancet, reports on the results of a Phase 3 study to assess the efficacy and tolerability of a monovalent human-bovine rotavirus vaccine (116E) for severe rotavirus gastroenteritis in low-resource urban and rural …
Author: Bhandari N, Rongsen-Chandola T, Bavdekar A, et al.
- Efficacy of Human Rotavirus Vaccine Against Rotavirus Gastroenteritis During the First 2 Years of Life in European Infants: Randomised, Double-Blind Controlled Study
This article, published in The Lancet, presents data that show high efficacy for GSK's Rotarix® administered with routine vaccines. Over two seasons, Rotarix® demonstrated 90 percent efficacy against severe rotavirus among European …
Author: Vesikari T, Karvonen A, Prymula R, et al.
- Efficacy of Pentavalent Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Infants in Developing Countries in Asia: A Randomised, Double-Blind, Placebo-Controlled Trial
This article, published in The Lancet, assesses the clinical efficacy of the pentavalent, live oral rotavirus vaccine for the prevention of severe rotavirus gastroenteritis in infants in Bangladesh and Vietnam. Study results demonstrated vaccine …
Author: Zaman K, Dang DA, Victor JC, et al.
- Efficacy of Pentavalent Rotavirus Vaccine Against Severe Rotavirus Gastroenteritis in Infants in Developing Countries in Sub-Saharan Africa: A Randomised, Double-Blind, Placebo-Controlled Trial
This article, published in The Lancet, shares results of an efficacy study of the pentavalent, live oral rotavirus vaccine in Ghana, Kenya, and Mali. Results showed 39.3 percent efficacy against severe rotavirus gastroenteritis. The authors …
Author: Armah GE, Sow SO, Breiman RF, et al.